| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2016-06-08 15:54:42 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm holds First Quarter 2016 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled today at 16:00 (EET). To join the webinar please follow the instructions below. Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities, provide more detailed information about the recent acquisition - company “Tonus Elast” and analyze the financial results of the first quarter 2016. During the webinar the attached presentation will be presented.
What is
webinar?
How to join the
webinar? To join the webinar, we invite you to register via ej.uz/OLF_Q1_2016.
You will be provided
with the webinar link and instructions to join webinar
successfully. When joining the webinar for the first time, you will
be asked to download the system application on your computer which
will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. Information
prepared by: |
| Pielikumi |